A first-line antiretroviral therapy-resistant HIV patient with rhinoentomophthoromycosis.

Dhurat, Rachita; Kothavade, Rajendra J; Kumar, Anand

Dhurat, Rachita; Kothavade, Rajendra J; Kumar, Anand.

Affiliation

Dhurat R; Department of Dermatology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, Maharashtra, India.
Kothavade RJ; Department of Medical Microbiology, Sepsis Research Group, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Kumar A; Department of Medical Microbiology, Sepsis Research Group, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Indian J Med Microbiol ; 36(1): 136-139, 2018.

Article in En | MEDLINE | ID: mdl-29735845

Subject(s)

Anti-Retroviral Agents/therapeutic use; Antifungal Agents/therapeutic use; Conidiobolus/drug effects; Drug Resistance, Fungal; Itraconazole/therapeutic use; Zygomycosis/drug therapy; Adult; Atazanavir Sulfate/therapeutic use; Drug Resistance, Viral; HIV Infections; Humans; Immunocompromised Host; Lamivudine/therapeutic use; Male; Potassium Iodide/therapeutic use; Ritonavir/therapeutic use; Tenofovir/therapeutic use; Zygomycosis/complications; Zygomycosis/microbiology

Key words

AIDS; Conidiobolus coronatus; HIV; antiviral drugs; rhinoentomophthoromycosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Itraconazole / Conidiobolus / Zygomycosis / Drug Resistance, Fungal / Anti-Retroviral Agents / Antifungal Agents Limits: Adult / Humans / Male Language: En Journal: Indian J Med Microbiol Year: 2018 Document type: Article

Fulltext

XML

PubMed Links

Search on Google